Monopoly Concerns with Oncology Acquisitions: Should We Be Worried?

Activity

Progress
1
Course Completed
Activity Information

Released: November 13, 2024

Expiration: November 12, 2025

John Marshall
John Marshall, MD
Never Miss an Episode of Oncology Unscripted

Subscribe Now
Catch Up On All Episodes of Oncology Unscripted

Watch Now

Monopoly Concerns with Oncology Acquisitions: Should We Be Worried

[00:00:05] John Marshall, MD: Let's look a little bit at the business side of what's going on. You know, I've been kind of watching this big takeover of McKesson and Florida Cancer Specialists. Well, wouldn't you know what? There's in fact, of course, been some Federal Trade Commission pushback that this creates sort of, how could it not be a monopoly, when you've got everything from insurance to providers to drug people and everybody in the same game. It ends up becoming a monopoly out there. And, you know, I think it's right that we look at this because, you know, we do predict that there's going to be just, you know, just a few huge health care systems out there in our country. And we need to figure out how best to manage all of that to continue to provide the best care we can, for all of our patients and give access to everybody that we can get access to. So. Important stuff going on out there still, of course, in our business world.

Learn more by watching:
Oncology Unscripted: Are You Overdosing Your Patients? 

Candid Conversations With the Experts: Dose Matters with Dr Mark Ratain

This transcript has been lightly edited for clarity.